| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/02/2022 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 150k | $0.99 | $148.5k | | 08/02/2022 |
| 02/01/2022 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Restricted Stock Units | 55k | $0.00 | $0 | | 02/01/2022 |
| 08/03/2021 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 100k | $6.80 | $680k | | 08/03/2021 |
| 06/16/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $10.19 | $6.1k | | 06/16/2021 |
| 06/09/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 650 | $10.82 | $7k | | 06/09/2021 |
| 06/08/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $11.00 | $6.6k | | 06/08/2021 |
| 06/04/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $10.00 | $6k | | 06/04/2021 |
| 05/26/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $10.00 | $6k | | 05/26/2021 |
| 05/19/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $10.63 | $6.4k | | 05/19/2021 |
| 05/12/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.2k | $11.09 | $13.3k | | 05/12/2021 |
| 04/28/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 2.4k | $12.58 | $30.2k | | 04/28/2021 |
| 04/26/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $13.00 | $7.8k | | 04/26/2021 |
| 04/21/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $11.98 | $21.6k | | 04/21/2021 |
| 04/14/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $12.22 | $22k | | 04/14/2021 |
| 04/07/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $12.02 | $21.6k | | 04/07/2021 |
| 04/05/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $13.00 | $7.8k | | 04/05/2021 |
| 03/31/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $11.96 | $21.5k | | 03/31/2021 |
| 03/24/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $11.95 | $21.5k | | 03/22/2021 |
| 03/22/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $12.00 | $7.2k | | 03/22/2021 |
| 03/17/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.2k | $11.36 | $13.6k | | 03/17/2021 |
| 03/10/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $11.97 | $21.5k | | 03/10/2021 |
| 03/03/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $11.87 | $21.4k | | 03/03/2021 |
| 02/25/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $13.00 | $7.8k | | 02/24/2021 |
| 02/24/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 1.8k | $12.14 | $21.9k | | 02/24/2021 |
| 02/17/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 2.4k | $12.70 | $30.5k | | 02/17/2021 |
| 02/05/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 600 | $14.00 | $8.4k | | 02/05/2021 |
| 02/03/2021 | Neoleukin Therapeutics, Inc. | AQXP | Sale | Common Stock | 2.4k | $13.23 | $31.8k | | 02/03/2021 |
| 01/30/2021 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 45k | $12.60 | $567k | | 01/30/2021 |